Clinical Trials · NCT03534661
L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- University Health Network, Toronto
- Enrollment
- 10
- Start date
- Sep 2017
- Locations
- 1 site, Canada
- Primary endpoint
- Plasma Lipid Levels